Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | est un(e) (attribut) | BAtx botulism antitoxin unspecified | false | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | a pour principe actif (attribut) | Botulinum antitoxin (substance) | true | Inferred relationship | Some | 1 | |
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | Has supplier | Novartis Vaccines and Diagnostics (supplier) | true | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | est un(e) (attribut) | Product containing only botulinum antitoxin (medicinal product) | true | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | Count of active ingredient | trois | false | Inferred relationship | Some | ||
| Botulism Antitoxin Behring solution for infusion Novartis Vaccines and Diagnostics (real clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR